Literature DB >> 16280789

Urological intervention in patients with cystinuria is decreased with medical compliance.

Gyan Pareek1, Thomas H Steele, Stephen Y Nakada.   

Abstract

PURPOSE: Theoretically patients with cystinuria compliant with medical treatment should undergo fewer surgical procedures than those noncompliant with treatment. We describe a single urologist's experience (SYN) with the effects of medical management on the number of surgical interventions required in patients with cystinuria treated at our metabolic stone clinic (MSC).
MATERIALS AND METHODS: The records of 20 patients with cystine stones seen at our MSC (mean followup of 42.5 months) were evaluated. The number of surgical interventions (endourology or open surgery) during followup were recorded as surgical events. Patients were placed into a compliant or noncompliant category based on their attendance record at scheduled appointments at our MSC and whether they adhered to the prescribed medical regimen by report. Patients were classified in an active disease category if recent imaging revealed a clinically significant stone burden greater than 3 mm. Statistical analysis of the number of surgical events for stone-free patients compliant with treatment versus noncompliant was conducted (Student's t test).
RESULTS: Of the 20 patients 11 were categorized as compliant and 9 as noncompliant. Of the compliant patients the average number of surgical events was 1.0 per patient versus 4.0 in the noncompliant group (p <0.05). Of the 11 compliant patients 8 (73%) were stone-free compared to 3 (33%) in the noncompliant group.
CONCLUSIONS: The majority of our patients with cystinuria compliant with treatment underwent a significantly fewer number of surgical procedures per year than those noncompliant with treatment. Active medical management in patients with cystinuria compliant with treatment decreases the incidence of surgical interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280789     DOI: 10.1097/01.ju.0000181817.89703.66

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Clinical Outcomes for Cystinuria Patients with Unilateral Versus Bilateral Cystine Stone Disease.

Authors:  Manint Usawachintachit; Benjamin Sherer; Matthew Hudnall; David T Tzou; Kazumi Taguchi; Ryan S Hsi; Marshall Stoller; Thomas Chi
Journal:  J Endourol       Date:  2018-01-03       Impact factor: 2.942

2.  Early Recognition and Management of Rare Kidney Stone Disorders.

Authors:  Boss Goldstein; David S Goldfarb
Journal:  Urol Nurs       Date:  2017 Mar-Apr

3.  Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.

Authors:  Brian H Eisner; David S Goldfarb; Michelle A Baum; Craig B Langman; Gary C Curhan; Glenn M Preminger; John C Lieske; Gyan Pareek; Kay Thomas; Anna L Zisman; Dimitri Papagiannopoulos; Roger L Sur
Journal:  J Endourol       Date:  2020-04-06       Impact factor: 2.942

Review 4.  Pediatric nephrolithiasis: a systematic approach from diagnosis to treatment.

Authors:  Giuseppina Marra; Francesca Taroni; Alfredo Berrettini; Emanuele Montanari; Gianantonio Manzoni; Giovanni Montini
Journal:  J Nephrol       Date:  2018-04-21       Impact factor: 3.902

5.  Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children.

Authors:  Ralph J DeBerardinis; Curtis R Coughlin; Paige Kaplan
Journal:  J Urol       Date:  2008-10-31       Impact factor: 7.450

Review 6.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 7.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

8.  Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?

Authors:  Hakan Hasbey Koyuncu; Faruk Yencilek; Bilal Eryildirim; Kemal Sarica
Journal:  Urol Res       Date:  2010-01-15

9.  The impact of new technology in the treatment of cystine stones.

Authors:  Alberto Trinchieri; Emanuele Montanari; Giampaolo Zanetti; Renata Lizzano
Journal:  Urol Res       Date:  2007-04-18

Review 10.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.